PRO MEDICUS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 109.4 AUD | +1.35% |
|
+6.24% | +14.14% |
| Apr. 02 | Pro Medicus Limited authorizes a Buyback Plan. | CI |
| Apr. 01 | Pro Medicus Limited announces an Equity Buyback for 10,442,488 shares, representing 10% of its issued share capital. | CI |
| Sales 2024 * | 160M 105M | Sales 2025 * | 204M 133M | Capitalization | 11.42B 7.46B |
|---|---|---|---|---|---|
| Net income 2024 * | 79M 51.6M | Net income 2025 * | 103M 67.28M | EV / Sales 2024 * | 70.4 x |
| Net cash position 2024 * | 128M 83.29M | Net cash position 2025 * | 175M 114M | EV / Sales 2025 * | 55.2 x |
| P/E ratio 2024 * |
144
x | P/E ratio 2025 * |
110
x | Employees | - |
| Yield 2024 * |
0.35% | Yield 2025 * |
0.45% | Free-Float | 47.96% |
More Fundamentals
* Assessed data
More news
Latest transcript on Pro Medicus Limited
More press releases
| 1 day | +1.35% | ||
| 1 week | +6.24% | ||
| Current month | +5.43% | ||
| 1 month | +8.65% | ||
| 3 months | +9.30% | ||
| 6 months | +44.19% | ||
| Current year | +14.14% |
1 week
102.38
110.41
1 month
97.33111.70
Current year
85.60111.89
1 year
58.60111.89
3 years
36.54111.89
5 years
14.50111.89
10 years
0.79111.89
| Managers | Title | Age | Since |
|---|---|---|---|
Anthony Hall
FOU | Founder | - | 82-12-31 |
Sam Hupert
FOU | Founder | - | 82-12-31 |
Clayton Hatch
DFI | Director of Finance/CFO | - | 08-05-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sam Hupert
FOU | Founder | - | 82-12-31 |
Anthony Hall
FOU | Founder | - | 82-12-31 |
Peter Kempen
CHM | Chairman | 73 | 08-03-11 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.03% | 773 M€ | -.--% | - | |
| 0.01% | 10 M€ | -3.35% | - | |
| 0.01% | 7 M€ | +1.95% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 109.4 | +1.35% | 206,003 |
| 24-04-24 | 107.9 | +0.66% | 149,936 |
| 24-04-23 | 107.2 | +2.99% | 204,372 |
| 24-04-22 | 104.1 | +1.11% | 180,193 |
| 24-04-19 | 103 | +0.85% | 397,819 |
Delayed Quote Australian S.E., April 26, 2024 at 02:10 am EDT
More quotes
Pro Medicus Limited is an Australia-based healthcare informatics company. The Company provides a full range of medical imaging software and services to hospitals, imaging centers and health care groups in Australia, North America and Europe. Its products include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro and Visage Ease. Its Visage RIS is a radiology information systems (RIS) medical software for practicing of management, training, installation and professional services. Visage RIS capabilities include patient registration, billing, scheduling, typing, HL7 integration, financial reporting, digital dictation and voice recognition integration. Its Visage 7.0 is a healthcare imaging software that provides clinicians with visualization capability for rapidly viewing 2-D, 3-D and 4-D medical images and picture archive and communication system (PACS)/digital imaging software that is sold directly and to original equipment manufacturers (OEM), training, installation and others.
Calendar
2024-08-12
- Q4 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
109.4
AUD
Average target price
95.57
AUD
Spread / Average Target
-12.62%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +14.14% | 7.45B | |
| +4.36% | 32.47B | |
| +22.93% | 3.89B | |
| -16.29% | 3.15B | |
| -25.96% | 1.28B | |
| -36.14% | 1.09B | |
| -0.13% | 893M | |
| -35.42% | 902M | |
| -24.12% | 857M | |
| -18.47% | 693M |
- Stock Market
- Equities
- PME Stock
